A review of big biotech partnering trends and comprehensive directory of deals and alliances announced during 2014.
Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide.
The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities.
Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, stage of development, technology type and therapeutic indication.
Chapter 2 provides a review of the leading deals during 2014. Deals are listed by headline value, signed by bigbiotech, and most active bigbiotech. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.
Chapter 3 provides a comprehensive listing of the top 50 big biotech companies with a brief summary followed by a comprehensive listing of 2014 deals, as well as contract documents available in the public domain. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
Chapter 4 provides a comprehensive directory of all partnering deals announced during 2014.
The chapter is organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc), therapy area and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
The report series also includes numerous tables and figures that illustrate the trends and activities in bigpharma partnering and dealmaking during 2014.
In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of technologies and products during 2014.
Table Of Contents
Big Biotech Deals and Alliances of 2014 Executive Summary
Chapter 1 - Trends in dealmaking during 2014
1.1. Big biotech dealmaking activity 1.2. Partnering by deal type 1.3. Partnering by industry sector 1.4. Partnering by stage of development 1.5. Partnering by technology type 1.6. Partnering by therapy area
Chapter 2 - Leading deals during 2014
2.1. Introduction 2.2. Top deals by value during 2012
Chapter 3 - Big biotech deals during 2014
3.1. Introduction 3.2. How to use big biotech partnering deals 3.3. Big biotech partnering company profiles for 2014 Roche Teva Pharmaceuticals Amgen Novo Nordisk Merck KGaA Gilead Sciences Actavis Biogen Idec Celgene Allergan Valeant Pharmaceuticals CSL Shire UCB Grifols Endo International Sun Pharmaceutical Regeneron Pharmaceuticals Actelion Ipsen Alexion Pharmaceuticals Vertex Pharmaceuticals United Therapeutics Cubist Pharmaceuticals Salix Pharmaceuticals Jazz Pharmaceuticals Questcor Pharmaceuticals The Medicines Company LFB Group Alkermes Biomarin Pharmaceuticals Biocon PDL BioPharma Swedish Orphan Biovitrum Acorda Therapeutics Emergent BioSolutions Dendreon Medivation Seattle Genetics Pharmacyclics Zeltia Bavarian Nordic Galapagos NPS Pharmaceuticals Spectrum Pharmaceuticals Nektar Therapeutics Isis Pharmaceuticals SciClone Pharmaceuticals Genmab Morphosys
Chapter 4 - Partnering deals directory 2014
4.1. Introduction 4.2. Company A-Z 4.3. By deal type 4.4. By stage of development 4.5. By technology type 4.6. By therapy area
About Wildwood Ventures
Current Partnering Current Agreements Current Reports Recent titles from CurrentPartnering Order Form - Reports
Table of figures
Figure 1: Big biotech - top 50 - January to December 2014 Figure 2: Big biotech deal frequency - 2014 Figure 3: Partnering by deal type during 2014 Figure 4: Partnering by industry sector during 2014 Figure 5: Partnering by stage of development during 2014 Figure 6: Partnering by technology type during 2014 Figure 7: Partnering by therapy area during 2014 Figure 8: Top deals by value during 2014